biomed devic servic
model updat maintain hold pt
updat model reflect zimmer adopt sever previous disclos
new account standard revenu recognit custom contract report
pension cost hedg activ compani adopt chang effect
januari recent provid updat histor financi
reflect retrospect adopt new standard new account
polici result materi chang histor result
nonetheless updat model reflect compani report move
forward addit also tweak forward estim incorpor
slightli conserv revenu ramp higher cog oper
spend relat quality/manufactur remedi sale channel incentives/
invest thu maintain hold rate lower price target
price close busi april
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
chang estim
adjust revenu estim
pro forma ep estim
adjust revenu estim
pro forma ep estim
adjust revenu estim
pro forma ep estim
adjust revenu estim
pro forma ep estim
adjust revenu estim
pro forma ep estim
adjust revenu estim
pro forma ep estim
adjust revenu estim
pro-forma ep estim
figur chang estim
broad large-cap med-tech group current trade mean price-to-earnings multipl
valu zimmer discount large-cap med-tech group given
uncertainti surround remedi suppli issu impact revenu
margin sum lower price target base price-to-earnings
multipl appli pro-forma ep
hold unchang target price april
biomed devic servic
figur matrix discount rate impli share price target
hold unchang target price april
biomed devic servic
comp pe multipl price metric use price-to-earnings valuat analysisbroad large-cap medic devic price-to-earnings multipl adjust pro-forma figur incom statement
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
hold unchang target price april
biomed devic servic
zimmer biomet incom statementcanaccord genuiti kyle except per share good devic gener asset op incom chg chg amort stk incom minor incom ep ep one-tim ep chg share gener oper rate adjust growth growth ep ex figur pro forma revenu build
hold unchang target price april
biomed devic servic
zimmer biomet revenu buildcanaccord genuiti kyle euro yen fx impact impact fx growth growth zimmer biomet hold
